Cafepharma Today

April 25 2025 - US pharma tariffs would raise US drug costs by $51 billion annually, report finds
US pharma tariffs would raise US drug costs by $51 billion annually, report finds
AbbVie hikes its outlook on the back of two powerhouse drugs
Big Pharma is investing billions in AI— and the value is finally starting to show
AstraZeneca enters $200m AI cancer pact with Tempus and Pathos
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

US pharma tariffs would raise US drug costs by $51 billion annually, report finds
Yahoo/Reuters
Friday, April 25, 2025 - 11:39am
tags:
tariffs, Donald Trump, drug pricing, PhRMA
US court decision stops compounders from making knockoffs of Novo Nordisk's semaglutide
Fierce Pharma
Friday, April 25, 2025 - 11:32am
tags:
Novo Nordisk, legal, semaglutide, drug compounding
AbbVie hikes its outlook on the back of two powerhouse drugs
Investors Business Daily
Friday, April 25, 2025 - 11:23am
tags:
AbbVie, Skyrizi, Rinvoq, earnings
Big Pharma Is Investing Billions In AI— And The Value Is Finally Starting To Show
Forbes
Friday, April 25, 2025 - 11:21am
tags:
artificial intelligence
Caribou, in reversal, scraps autoimmune cell therapy and cuts staff
BioPharma Dive
Friday, April 25, 2025 - 11:19am
tags:
Caribou Biosciences, CRISPR, layoffs, lupus, cancer, cell therapy
FDA puts Vyne in a twist, slapping hold on psoriasis trial over testicular toxicity concerns
Fierce Biotech
Friday, April 25, 2025 - 11:17am
tags:
Vyne Therapeutics, FDA, psoriasis, clinical trials
Samsung Bioepis releases Q2 2025 Biosimilar Market report
Drug Store News
Friday, April 25, 2025 - 11:12am
tags:
Samsung Bioepis, biosimilars, Stelara
AstraZeneca enters $200m AI cancer pact with Tempus and Pathos
Yahoo Finance
Friday, April 25, 2025 - 10:49am
tags:
AstraZeneca, Tempus AI, Pathos AI
Medtronic seeks FDA nod for insulin pump, furthering Abbott collab
Medtech Dive
Friday, April 25, 2025 - 10:47am
tags:
Medtech, Medtronic, FDA, insulin pump, Abbott Labs, CGMs, diabetes
Flagship’s latest venture reflects more than 25 years of leaping into the unknown
Pharma Voice
Friday, April 25, 2025 - 10:45am
tags:
Flagship Pioneering, artificial intelligence, Etiome
AbbVie files fast-acting Botox successor in US
Pharmaphorum
Friday, April 25, 2025 - 10:41am
tags:
AbbVie, TrenibotE, Botox, aesthetics
Sen. Cassidy calls for 340B reform, increased oversight of hospitals, contract pharmacies
Fierce Healthcare
Thursday, April 24, 2025 - 9:21pm
tags:
340B, healthcare reform, Bill Cassidy, hospitals
Gilead Dives After Its Bread-And-Butter Drug Misses Sales Forecasts
Investors Business Daily
Thursday, April 24, 2025 - 9:18pm
tags:
Gilead Sciences, earnings, Biktarvy, Trodelvy
Halozyme sues Merck over subcutaneous Keytruda as licensing talks fall through
Fierce Pharma
Thursday, April 24, 2025 - 9:17pm
tags:
Halozyme, Merck, Keytruda, patents, legal
Why the Future of Medical Device Manufacturing Runs Through Mexico
Medical Devices and Diagnostics Industry
Thursday, April 24, 2025 - 9:15pm
tags:
Medtech, devices, device manufacturing, tariffs, Mexico
Ex-FDA leader joins new initiative designed to fight 'unfortunate reality' of vaccine landscape
Fierce Biotech
Thursday, April 24, 2025 - 9:14pm
tags:
vaccines, FDA, Margaret Hamburg, HHS, misinformation
Germany's Merck says in late-stage discussions to buy SpringWorks for $3.5 billion
Yahoo/Reuters
Thursday, April 24, 2025 - 9:12pm
tags:
Merck KGaA, SpringWorks Therapeutics, M&A
Bristol Myers says schizophrenia drug launch ‘off to a solid start’
BioPharma Dive
Thursday, April 24, 2025 - 9:11pm
tags:
Bristol Myers Squibb, schizophrenia, Cobenfy, drug launches
Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs
CNBC
Thursday, April 24, 2025 - 11:28am
tags:
Bristol Myers Squibb, earning, tariffs
Roche in ‘very, very good position’ to weather Trump tariffs, but M&A may suffer
BioSpace
Thursday, April 24, 2025 - 11:24am
tags:
Roche, earnings, tariffs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Glioblastoma Treatment
In the Pipeline
Streptomycin For Metastatic Cancer
In the Pipeline
The End of Disease
In the Pipeline
You Can Probably Smell That Planet From Here
In the Pipeline
Proton Pump Inhibitors Do More Than You Think
In the Pipeline
Entropy, Enthalpy, and Hydrophobicity
In the Pipeline
The Continuing Crisis, Part XII: Behold RFK Jr.'s FDA
In the Pipeline
RNA Motifs Coming Into Focus
In the Pipeline
Pharmaceutical Tariffs: The What and the How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.